492 results on '"Onozawa Y"'
Search Results
2. 225P Nivolumab for cancer of unknown primary (CUP): Clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M)
3. 851MO Final analysis of a phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of the head and neck (JCOG1008)
4. P-95 Bevacizumab, irinotecan and biweekly trifluridine/tipiracil for pretreated metastatic colorectal cancer: MODURATE, a phase Ib study
5. An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumors
6. Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer
7. Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors
8. Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution
9. SAFETY AND EFFICACY OF PROTON-BEAM RADIATION THERAPY FOR PATIENTS WITH LOCALLY RECURRENT RECTAL CANCER
10. EFFICACY AND SAFETY OF CHEMORADIOTHERAPY FOR PATIENTS WITH LOCOREGIONAL LYMPH NODE RECURRENCE OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA
11. IS ADJUVANT CHEMORADIOTHERAPY NECESSARY FOR HIGH-RISK OROPHARYNGEAL CANCER AFTER SURGERY?
12. CORRELATION BETWEEN THE EFFECTS OF FIRST-LINE CHEMOTHERAPY AND SURVIVAL TIME FROM SECOND-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
13. P-69 Efficacy and safety of S-1 following gemcitabine with cisplatin for biliary tract cancer
14. Incidence and influence of GB virus C and hepatitis C virus infection in patients undergoing bone marrow transplantation
15. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution
16. Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation
17. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer
18. O2–083 - Outcome of Anti-Egfr Antibody Therapy in Metastatic Colorectal Cancer with Low-Frequency Kras Mutations
19. Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive non-Hodgkin's lymphoma
20. Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients
21. Microangiopathy without hemolysis in a patient following allogeneic bone marrow transplantation
22. Risk of Ischemic Heart Disease in Patients After Conccurent Chemoradiotherapy for Lung and Esophageal Cancer: A Case-Control Study
23. Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes
24. Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: A supplementary analysis of a phase II trial (JCOG0706S1)
25. Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
26. Preventive effect of nutrition support on peroneal neuropathy in cancer patients
27. Clinical and immunological investigations in cryptogenic new-onset refractory status epilepticus (Norse)
28. Hole path concept for low switching loss and low EMI noise with high IE-effect
29. 218TiP A phase Ib study of irinotecan, bevacizumab and biweekly TAS-102 in Japanese patients with metastatic colorectal cancer refractory to fluoropyrimidine and oxaliplation (MODURATE)
30. Risk factors for esophageal fistula in esophageal squamous cell carcinoma invading adjacent organs (T4b) treated with definitive chemoradiotherapy
31. 61. Evaluation of the regional lymph node for cervical esophageal squamous cell carcinoma: Proposed selection for improved survival stratification
32. Trench shielded gate concept for improved switching performance with the low miller capacitance
33. 1111P - Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
34. 1112P - Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: A supplementary analysis of a phase II trial (JCOG0706S1)
35. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma
36. 165P Neutropenia as a predictive factor in patients with metastatic colorectal cancer treated with TAS-102
37. SUN-PP136: Changes in Body Weight and Body Mass Index After Esophagectomy
38. The compact and high power density 7th generation IGBT module
39. The advanced 7th generation IGBT module for high power density technology
40. Ultra low miller capacitance trench-gate IGBT with the split gate structure
41. Clinicopathological Features and Outcomes of Gastric Cancer Patients with Pulmonary Lymphangitis Carcinomatosa
42. The role of mitochondria-derived reactive oxygen species in the pathogenesis of non-steroidal anti-inflammatory drug-induced small intestinal injury
43. Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
44. 668P - Risk factors for esophageal fistula in esophageal squamous cell carcinoma invading adjacent organs (T4b) treated with definitive chemoradiotherapy
45. Cisplatin/5-FU 100/1000 in Japanese Patients With Recurrent/Metastatic SCCHN
46. Outcome of Anti-Egfr Antibody Therapy in Metastatic Colorectal Cancer with Low-Frequency Kras Mutations
47. Efficacy and Safety of Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer
48. Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
49. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
50. The compact and high power density 7th generation IGBT module.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.